Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
Safety and Pharmacokinetics (PK) of a once daily topical application of efinaconazole in the
treatment of pediatric subjects with mild to severe onychomycosis of the toenails.
Phase:
Phase 4
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.